Podcast Episodes
Back to Search
ACR 2021: Day 2 Highlights
Grace Wright presents the Day 2 highlights of the key abstracts and posters presented at ACR 2021.
4 years, 6 months ago
Discussing Rheumatology: Herpes Zoster and HBV
Prof Iain McInnes discusses the risk of herpes zoster in RA patients taking biologics and DMARDS. He also discusses reactivation of hepatitis B in p…
4 years, 7 months ago
ACR 2021: Day 1 Highlights
Prof Calabrese presents the Day 1 highlights of the key abstracts and posters presented at ACR 2021.
4 years, 7 months ago
ACR 2021 Preview Podcast
A preview of the latest research at ACR 2021. Prof Ritchlin highlights important abstracts in cytokine signalling at the upcoming ACR Convergence.
4 years, 7 months ago
Rheumatology Author Professor Paul Bird: Tofacitinib Effectiveness
Paul Bird, Conjoint Professor at the University of South Wales. Join Professor Peter Nash as he interviews authors of recent notable papers in rheuma…
4 years, 7 months ago
Discussing Rheumatology: Poor Prognostic Factors, Monotherapy, and Combination Therapy
Prof Iain McInnes discusses poor prognostics factors from the FINCH 3 study, and the effectiveness and persistence of monotherapy and combination the…
4 years, 8 months ago
Rheumatology Author Professor Kurt de Vlam: Pain Improvements
Kurt de Vlam, Professor of Rheumatology at UZ Leuven, Belgium. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumat…
4 years, 8 months ago
Rheumatology Author Professor Strand: Upadacitinib and PROs
Vibeke Strand, Adjunct Clinical Professor in the Division of Immunology/Rheumatology, Biopharmaceutical Consultant at Stanford University School of M…
4 years, 8 months ago
Discussing Rheumatology: Patient Reported Outcomes
Prof Iain McInnes discusses an essential part of the assessment of patients with rheumatic diseases; patient reported outcomes, or PROs. Improving PR…
4 years, 8 months ago
Discussing Rheumatology: SELECT-PsA 2 and DMARDs in COVID-19
Prof Iain McInnes discusses long-term data from the SELECT-PsA 2 study, and the impact of DMARDs on COVID-19 outcomes. Keep-up to date with the lates…
4 years, 10 months ago